SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001140361-18-038676
Filing Date
2018-09-18
Accepted
2018-09-18 17:11:16
Documents
10
Effectiveness Date
2018-09-18

Document Format Files

Seq Description Document Type Size
1 S-3ASR s002406x1_s3asr.htm S-3ASR 567997
2 EXHIBIT 4.4 s002406x1_ex4-4.htm EX-4.4 382003
3 EXHIBIT 4.7 s002406x1_ex4-7.htm EX-4.7 113799
4 EXHIBIT 4.8 s002406x1_ex4-8.htm EX-4.8 114272
5 EXHIBIT 4.9 s002406x1_ex4-9.htm EX-4.9 103882
6 EXHIBIT 5.1 s002406x1_ex5-1.htm EX-5.1 28874
7 EXHIBIT 23.1 s002406x1_ex23-1.htm EX-23.1 2896
8 image0.jpg GRAPHIC 32202
9 image1.jpg GRAPHIC 28720
10 logo_akcea.jpg GRAPHIC 16287
  Complete submission text file 0001140361-18-038676.txt   1421279
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-227403 | Film No.: 181076340
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1